Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
54.1M
-
Shares change
-
+753K
-
Total reported value, excl. options
-
$9.02B
-
Value change
-
+$127M
-
Put/Call ratio
-
1.36
-
Number of buys
-
89
-
Number of sells
-
-60
-
Price
-
$166.78
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2020
195 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2020.
Ascendis Pharma A/S - ADR (ASND) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.1M shares
of 55.6M outstanding shares and own 97.33% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (6.62M shares), RA CAPITAL MANAGEMENT, L.P. (5.87M shares), Artisan Partners Limited Partnership (5.77M shares), FMR LLC (5.34M shares), BAKER BROS. ADVISORS LP (3.54M shares), WELLINGTON MANAGEMENT GROUP LLP (3.4M shares), JANUS HENDERSON GROUP PLC (3.01M shares), Avoro Capital Advisors LLC (1.8M shares), Vivo Capital, LLC (1.8M shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (1.73M shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.